2021-01-04,Krystal Biotech Appoints Dr. Chris Mason and Dr. Jing Marantz to its Board of Directors
2020-12-10,Is KRYS A Good Stock To Buy Now?
2020-11-24,Krystal Biotech to Present at the Evercore ISI HealthCONx Conference
2020-11-09,Krystal Biotech Reports Third Quarter 2020 Financial Results and Provides Update on Operational Progress
2020-10-16,Krystal Biotech Announces Departure of Chief Commercial Officer
2020-10-08,Krystal Biotech to Present Pre-clinical Data Highlighting KB301 for Aesthetic Indications at the ASDS 2020 Virtual Meeting
2020-09-24,Krystal Biotech to Present at Upcoming Investor Conferences
2020-09-09,Krystal Biotech to Present at HC Wainwright and Morgan Stanley Healthcare Conferences
2020-08-25,Krystal Biotech Announces Initiation of Phase 1 Study Evaluating KB301 in Aesthetic Indications
2020-08-18,"The Daily Biotech Pulse: Poseida's Phase 1 Study Placed On Clinical Hold, Orphan Drug Designation For Krystal Biotech, Tiziana's Patent Award"
2020-08-18,Krystal Biotechs Promising Cystic Fibrosis Drug Scores Orphan Designation
2020-08-17,Krystal Biotechs KB407 Granted Orphan Drug Designation by the FDA to Treat Patients With Cystic Fibrosis
2020-08-11,"What Type Of Shareholders Own The Most Number of Krystal Biotech, Inc. (NASDAQ:KRYS) Shares?"
2020-08-11,"What Kind Of Investors Own Most Of Krystal Biotech, Inc. (NASDAQ:KRYS)?"
2020-08-10,Krystal Biotech Reports Second Quarter 2020 Financial Results and Provides Update on Operational Progress
2020-07-30,Krystal Biotech to Present at the William Blair BioTech Conference
2020-07-28,Krystal Biotech Announces Initiation of Pivotal Phase 3 Study of Beremagene Geperpavec in Patients with Dystrophic Epidermolysis Bullosa
2020-07-20,"Krystal Biotech Appoints Whitney Ijem as Senior Vice President, Strategy and Business Development"
2020-06-26,"Krystal Biotech, Inc. (KRYS): Hedge Funds In Wait-and-See Mode"
2020-06-08,Krystal Biotech to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast
2020-05-25,7 Perfect 10 Stocks to Buy Now
2020-05-19,8 Biotechs Tapping Secondary Markets for $3 Billion
2020-05-18,Krystal Biotech Announces Pricing of $125 Million Public Offering of Common Stock
2020-05-18,Krystal Biotech Announces Proposed Public Offering of Common Stock
2020-05-14,Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Trial of KB105 in Patients with TGM1-related Autosomal Recessive Congenital Ichthyosis (ARCI)
2020-05-04,Krystal Biotech Reports First Quarter 2020 Financial Results and Provides Update on Operational Progress
2020-04-21,Outlook Therapeutics Bolsters Clinical and Commercial Expertise with Two Key Appointments to Board of Directors
2020-04-01,"How Does Investing In Krystal Biotech, Inc. (NASDAQ:KRYS) Impact The Volatility Of Your Portfolio?"
2020-03-10,Krystal Biotech Reports 2019 Financial Results and Business Progress
2020-02-25,"Krystal Biotech CFO resigns, new accounting officer named"
2020-02-25,Krystal Biotech Announces Change in Financial Leadership
2020-02-21,Krystal Biotech to Present at the Cowen 40th Annual Healthcare Conference
2020-01-24,Krystal Biotech Breaks Ground On Second Commercial Gene Therapy Manufacturing Facility
2020-01-21,Krystal Biotech Appoints Jennifer Chien as Chief Commercial Officer
2020-01-02,Companies Like Krystal Biotech (NASDAQ:KRYS) Are In A Position To Invest In Growth
2019-12-23,"Krystal Biotech, Inc. (KRYS) is a Great Momentum Stock: Should You Buy?"
2019-12-14,"Hedge Funds Dropped The Ball On Krystal Biotech, Inc. (KRYS)"
2019-12-12,"The Zacks Analyst Blog Highlights: ACADIA, Compugen, Cue Biopharma, Epizyme and Krystal Biotech"
2019-12-11,5 Biotech Stocks Up More Than 100% This Year So Far
2019-12-03,"Krystal Biotech, Inc. (KRYS) Shares March Higher, Can It Continue?"
2019-11-26,Krystal Biotech to Present at the Piper Jaffray 31st Annual Healthcare Conference
2019-11-14,"Here's Why Krystal Biotech, Inc. (KRYS) is a Great Momentum Stock to Buy"
2019-11-04,Krystal Biotech Reports Third Quarter 2019 Financial and Operating Results
2019-10-30,"Here is What Hedge Funds Think About Krystal Biotech, Inc. (KRYS)"
2019-10-29,"Krystal Biotech Announces Final Update from Phase 1/2 Clinical Trial of KB103 (""bercolagene telserpavec,"" ""B-VEC"")"
2019-10-10,Krystal Biotech Receives Positive EMA Opinion on Orphan Designation for KB105 to Treat Patients With TGM1 Deficient Autosomal Recessive Congenital Ichthyosis
2019-10-04,"Before You Buy Krystal Biotech, Inc. (NASDAQ:KRYS), Consider Its Volatility"
2019-09-30,Krystal Biotech to Present at the Cantor 2019 Global Healthcare Conference andÂ Chardan's 3rd Annual Genetic Medicines Conference
2019-09-27,Krystal Biotech Announces Granting of its First Foreign Patent and Reinforces its IP Portfolio with a New U.S. Patent
2019-09-04,Krystal Biotech Announces Initiation of Phase 1/2 Study of KB105 in Transglutaminase-1 (TGM1) Deficient Autosomal Recessive Congenital Ichthyosis (ARCI)
2019-08-27,Krystal Biotech Announces Attendance at Citis 14th Annual Biotech Conference
2019-08-14,"Have Insiders Been Buying Krystal Biotech, Inc. (NASDAQ:KRYS) Shares?"
2019-08-05,Krystal Biotech Reports Second Quarter 2019 Financial and Operating Results
2019-07-01,"Krystal Biotech, Inc. Added to the Russell 2000 Index"
2019-07-01,3 Small-Cap Biotech Stocks That Soared Last Week
2019-06-27,"Hedge Funds Have Never Been This Bullish On Krystal Biotech, Inc. (KRYS)"
2019-06-25,"Krystal Biotech Analyst Lifts Price Target More Than 50% On Positive Phase 2 Data, RMAT Designation"
2019-06-25,"The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership"
2019-06-24,"Why NRC Group Holdings, PCM, and Krystal Biotech Jumped Today"
2019-06-24,Krystal Biotech Rallies On Positive Trial Results For Skin Condition
2019-06-24,Krystal Biotech stock jumps after positive clinical trial results
2019-06-24,Krystal Biotech shares up 27% after company's skin drug receives expedited review designation from FDA
2019-06-24,Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial (GEM-2 study) of KB103 and Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for KB103
2019-06-14,"Krystal Submits Investigational New Drug (IND) Application for KB105, Topical Gene Therapy Candidate for Transglutaminase-1 Deficient Autosomal Recessive Congenital Ichthyosis"
2019-05-15,Krystal Biotech to Present at the RBC Capital Markets 2019 Healthcare Conference
2019-05-06,Krystal Biotech Reports First Quarter 2019 Financial Results and Provides Corporate Update
2019-04-29,Krystal Biotech Announces Five Presentations of Clinical and Preclinical Data at the Society for Investigative Dermatology Annual Meeting
2019-03-29,EMA Grants PRIME Eligibility for KB103 to Treat Dystrophic Epidermolysis Bullosa
2019-03-12,Krystal Biotech Reports 2018 Financial Results and Business Progress
2019-03-07,Krystal (KRYS) in Focus: Stock Moves 5.1% Higher
2019-03-06,Krystal Biotech Continues Vertical Integration with Official Inauguration of Ancoris Gene Therapy Manufacturing Facility at its Pittsburgh Headquarters
2019-03-04,Krystal Strengthens Board of Directors with Appointment of Julian S. Gangolli
2019-03-01,Krystal Biotech to Present at the Cowen and Company 39th Annual Health Care Conference
2019-02-22,Krystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference
2019-01-18,"Danforth Advisors entering Pittsburgh, focusing on life sciences sector"
2019-01-15,Krystal Biotech Completes Construction of Ancoris - A New GMP Facility for Commercial Manufacturing of a Viral Vector-Based Gene Therapy to Treat Dystrophic Epidermolysis Bullosa
2018-12-19,Krystal Biotech Completes Dosing in the GEM-Phase 2 Study in Pediatric Patients for the Treatment of Dystrophic Epidermolysis Bullosa
2018-11-21,"New Research Coverage Highlights VSE, Weyco Group, Funko, B. Riley Financial, Krystal Biotech, and Xcel Brands  Consolidated Revenues, Company Growth, and Expectations for 2018"
2018-11-20,Krystal Biotech to Present at Evercore ISI HealthCONx
2018-11-05,Krystal Biotech Reports Third Quarter 2018 Financial Results and Provides Corporate Update
2018-10-23,Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters Over-Allotment Option
2018-10-22,"Krystal Biotech Inc (KRYS) President and CEO Krish S Krishnan Bought $500,000 of Shares"
2018-10-22,Chardan Serves as Lead Manager for Krystal Biotech
2018-10-18,Krystal Biotech Announces Pricing of $60.0 Million Public Offering of Common Stock
2018-10-17,Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock
2018-10-15,Krystal Biotech Announces Positive Interim Results from Placebo-Controlled Phase 1/2 Clinical Trial of KB103
2018-10-04,Krystal Biotech to Present at Chardan Annual Genetic Medicines Conference
2018-10-01,Krystal Biotech to Present at 2018 Cell & Gene Meeting on the Mesa
2018-09-25,Krystal Biotech to Present at Upcoming Cantor Fitzgerald and Ladenburg Thalmann Conferences
2018-08-29,Krystal Biotech to Present at Upcoming B. Riley FBR and H.C. Wainwright Healthcare Investor Conferences
2018-08-23,Krystal Biotechs KB105 Receives Rare Pediatric Disease Designation from the FDA to Treat Patients with TGM-1-deficient Autosomal Recessive Congenital Ichthyosis
2018-08-17,Chardan Capital Markets acts as Sole Placement Agent in $10 Million Securities Purchase
2018-08-16,Krystal Biotech Announces $10 Million Private Placement with Frazier Healthcare Partners
2018-08-09,Krystal Biotechs KB105 Granted Orphan Drug Designation by the FDA to Treat Patients With TGM-1 Deficient Autosomal Recessive Congenital Ichthyosis
2018-08-06,Krystal Biotech Reports Second Quarter 2018 Financial Results and Provides Corporate Update
2018-07-16,Krystal Biotech to Present Update on KB103 Program for Treatment of Dystrophic Epidermolysis Bullosa at debra Care Conference 2018
2018-07-13,"Krystal Biotech (KRYS) Shares March Higher, Can It Continue?"
2018-06-08,Can the Rally in Krystal Biotech (KRYS) Shares Continue?
2018-05-29,Blog Exposure - Krystal Biotechs KB103 Granted Fast Track Designation by FDA for Treatment of Dystrophic Epidermolysis Bullosa
2018-05-24,U.S. FDA Grants Fast Track Designation for Krystal Biotechs KB103 for the Treatment of Dystrophic Epidermolysis Bullosa
